Efficacy and safety of anti-PD-1/PD-L1 combinations versus standard of care in cancer: a systematic review and meta-analysis.

Immune checkpoint inhibitors (ICIs) as monotherapy in different solid tumors showed an early detrimental effect in a subset of patients reflected by the early crossover of the progression-free survival (PFS) curves. Currently, combination therapies with ICIs added to chemotherapy or targeted therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Carretero-González, Alberto, Otero, Irene, Lora, David, Carril-Ajuria, Lucía, Castellano, Daniel, de Velasco, Guillermo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906255/
https://www.ncbi.nlm.nih.gov/pubmed/33680572
http://dx.doi.org/10.1080/2162402X.2021.1878599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906255/
https://www.ncbi.nlm.nih.gov/pubmed/33680572
http://dx.doi.org/10.1080/2162402X.2021.1878599

Ejemplares similares